Open Government Canada
Registration Decision RD2021-06, Fluazaindolizine and Salibro Nematicide
Published by Health Canada | Santé Canada
About this dataset
This decision is consistent with the Proposed Registration Decision PRD2021-03, Fluazaindolizine and Salibro Nematicide, whichcontains a detailed evaluation of the information submitted in support of this registration.